NOT-FD-22-005: Notice to Extend the Application Due Date for RFA-FD-22-006 "Conformance with the Egg Regulatory Program Standards (U2F) Clinical Trial Not Allowed"

Notice to Extend the Application Due Date for RFA-FD-22-006 "Conformance with the Egg Regulatory Program Standards (U2F) Clinical Trial Not Allowed"

Notice Number:

NOT-FD-22-005

Key Dates

Release Date:

January 18, 2022

Related Announcements

RFA-FD-22-006 Conformance with the Egg Regulatory Program Standards (U2F) Clinical Trial Not Allowed

Issued by

U.S. Food and Drug Administration (FDA)

Purpose

This notice is to extend the Application Due Date for RFA-FD-22-006 Conformance with the Egg Regulatory Program Standards (U2F) Clinical Trial Not Allowed.

New Application Due Date(s)

February 28, 2022, by 11:59 PM Eastern Time

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the applications during the submission process by the due date.

Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.

Late applications will not be accepted for this FOA.

Inquiries

Please direct all inquiries to:

Kiara Farmer
Grants Management Specialist
Office if Acqusitions and Grants Services
Tel: 240-402-3099
Email: Kiara.Farmer@fda.hhs.gov